Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3932-3957
Author(s):
Ana R. Quesada, Miguel Angel Medina, Ramon Munoz-Chapuli and Angel Luis G. Ponce
CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3903-3920
Author(s):
S. Liekens, D. Schols and S. Hatse
Focal Adhesion Kinase as a Therapeutic Target of Bortezomib
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
747-752
Author(s):
Bor-Sheng Ko, Tzu-Ching Chang and Jun-Yang Liou
Focal Adhesion Kinase as a Cancer Therapy Target
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
735-741
Author(s):
Vita M. Golubovskaya
KRAS Mutation Testing of Colorectal Cancer for Anti-EGFR Therapy: Dogmas Versus Evidence
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
813-823
Author(s):
J. Timar, B. Hegedus and E. Raso
Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
898-913
Author(s):
D. Mottet and V. Castronovo
Editorial [Hot topic:Targeted Molecular Radiotherapy (Guest Editor: Veerle Kersemans)]
Journal:
Current Drug Discovery Technologies
Volume:
7
Page:
232-232
Author(s):
Veerle Kersemans
Current Concepts and Future Directions in Radioimmunotherapy
Journal:
Current Drug Discovery Technologies
Volume:
7
Page:
253-262
Author(s):
Frank I. Lin and Andrei Iagaru
Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Journal:
Current Drug Discovery Technologies
Volume:
7
Page:
263-279
Author(s):
Bart Cornelissen and Katherine A Vallis
MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
289-305
Author(s):
William Xu, Qi Zhao Wang, Qi Cui and Ruian Xu